Oncogenes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Oncogenes stocks.

Oncogenes Stocks Recent News

Date Stock Title
Nov 21 KURA Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Nov 21 KURA Analysts supportive of Kura/Kirin deal despite major selloff (update)
Nov 21 KURA Kura Oncology: A Contender In The Field Of Precision Medicine
Nov 21 KURA Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Nov 21 KURA Kura Oncology partners Kyowa Kirin to advance AML treatment
Nov 20 KURA Kura stock slides 17% on Kyowa Kirin deal for ziftomenib
Nov 20 KURA Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
Nov 20 SLXN Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
Nov 20 HCWB HCW Biologics prices $6.9M registered direct offering at $1.03 per share
Nov 19 BGNE Labcorp CFO Glenn Eisenberg Announces Plans to Retire
Nov 19 BGNE BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
Nov 19 HCWB HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement
Nov 19 HCWB HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
Nov 18 HCWB Top Midday Gainers
Nov 18 HCWB Why Is Penny Stock HCW Biologics Surging On Monday?
Nov 18 HCWB HCW Biologics jumps on license agreement for immunotherapeutic product candidate
Nov 18 HCWB HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
Nov 15 BGNE BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now
Nov 15 ERAS Erasca (ERAS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Nov 15 NVCT Nuvectis Pharma reports data from Phase 1b study of NXP800
Oncogenes

An oncogene is a gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels.Most normal cells will undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered and malfunctioning. Activated oncogenes can cause those cells designated for apoptosis to survive and proliferate instead. Most oncogenes began as proto-oncogenes, normal genes involved in cell growth and proliferation or inhibition of apoptosis. If normal genes promoting cellular growth, through mutation, are up-regulated, (gain of function mutation) they will predispose the cell to cancer and are thus termed oncogenes. Usually multiple oncogenes, along with mutated apoptotic or tumor suppressor genes will all act in concert to cause cancer. Since the 1970s, dozens of oncogenes have been identified in human cancer. Many cancer drugs target the proteins encoded by oncogenes.

Browse All Tags